Stocktoria
Liquidia Corp LQDA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-07-26
Liquidia Corp statistics & valuation
Market cap$7.0B
P / S43.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -32.5% | -866.6% | -419.6% | -243.3% | -263.0% |
| Net margin | -43.5% | -916.6% | -448.9% | -257.4% | -269.0% |
| FCF margin | -25.3% | -702.9% | -245.0% | -183.1% | -265.6% |
| Return on assets | -21.0% | -55.7% | -66.3% | -31.7% | -36.9% |
| Return on equity | -154.0% | -161.6% | -166.0% | -45.4% | -53.0% |
| Debt / equity | — | — | — | 0.22× | 0.16× |
| Current ratio | 2.01 | 4.43 | 4.85 | 11.34 | 8.36 |
| Revenue growth | 1031.2% | -20.0% | 9.7% | 24.0% | 1637.8% |
Source: SEC EDGAR filings · CIK 0001819576 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.